Prolo Pharmaceutical Co., Ltd. (Stock Code: 000739, Stock Abbreviation: Prolo Pharmaceutical) announces that the company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Important Content Reminder:
- Stock Option Abbreviation: Prolo JLC
- Stock Option Code: 037967
- Initial Grant Date of Stock Options: May 18, 2026
- Completion Date of Initial Grant Registration: June 4, 2026
- Total Number of Stock Options Granted: 6.029 million
- Number of Individuals Granted Stock Options: 93
- Exercise Price: 13.15 yuan per option
- Source of Stock: The company issues A-share common stock to the incentive recipients.
According to the "Management Measures for Equity Incentives of Listed Companies" by the China Securities Regulatory Commission and relevant regulations from the Shenzhen Stock Exchange and the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited, Prolo Pharmaceutical Co., Ltd. has completed the registration of the initial grant of stock options under the "2026 Stock Option Incentive Plan (Draft)." The relevant matters are announced as follows:
I. Decision-Making Process and Approval of the Incentive Plan
- On March 10, 2026, the company held the 18th meeting of the 9th Board of Directors, which approved the proposals regarding the "2026 Stock Option Incentive Plan (Draft)" and its summary, the "Implementation Assessment Management Measures for the 2026 Stock Option Incentive Plan," and the proposal to authorize the Board of Directors to handle matters related to the 2026 Stock Option Incentive Plan. These matters were reviewed and approved by the Board's Compensation and Assessment Committee.
- From March 11 to March 20, 2026, the company publicly announced the names and positions of the proposed incentive recipients through bulletin boards. During the announcement period, the Board's Compensation and Assessment Committee did not receive any objections related to the proposed incentive recipients. On March 24, 2026, the Compensation and Assessment Committee disclosed the "Explanation and Verification Opinion on the Publicity of the List of Incentive Recipients for the Initial Grant of the 2026 Stock Option Incentive Plan."
- On April 13, 2026, the company held the 2025 Annual General Meeting, which approved the proposals regarding the "2026 Stock Option Incentive Plan (Draft)" and its summary, the "Implementation Assessment Management Measures for the 2026 Stock Option Incentive Plan," and the proposal to authorize the Board of Directors to handle matters related to the 2026 Stock Option Incentive Plan. The implementation of this incentive plan was approved by the shareholders' meeting, and the Board was authorized to determine the grant date of stock options and grant stock options to eligible recipients while handling all necessary matters related to the grant.
- On April 14, 2026, the company disclosed the "Self-Examination Report on Insider Trading of Company Stock by Insiders and Incentive Recipients of the 2026 Stock Option Incentive Plan."
- On May 18, 2026, the company held the 3rd meeting of the 10th Board of Directors, which approved the proposal to adjust the exercise price of the 2026 Stock Option Incentive Plan and the proposal to grant stock options to the incentive recipients for the first time. These matters were reviewed and approved by the Board's Compensation and Assessment Committee, which verified the list of incentive recipients and issued a verification opinion.
II. Granting of Stock Options
- Stock Option Abbreviation: Prolo JLC
- Stock Option Code: 037967
- Initial Grant Date of Stock Options: May 18, 2026
- Completion Date of Initial Grant Registration: June 4, 2026
- Number of Individuals Granted Stock Options: 93
- Exercise Price: 13.15 yuan per option
- Source of Stock: The company issues A-share common stock to the incentive recipients.
- Distribution of Initial Grant Registration of Incentive Recipients: